Topics / Testosterone & Hormones
Testosterone & Hormones
Testosterone, TRT, estradiol, SHBG, thyroid and the growth hormone axis, against the labs and the trials.
12 guidesone evidence laddernot yet clinically reviewed
Start here
1Supplements
4- ShilajitHerbo-mineral resinA tar-like resin from Himalayan rock, used in Ayurveda for centuries. One small 90-day trial raised testosterone in men aged 45 to 55; one 8-week trial reduced strength loss after fatigue. Both used the same purified extract. Raw resin has tested over heavy-metal limits.Early clinical
- Tongkat aliHerbal root extractA Southeast Asian root sold to men for testosterone. Five small trials pooled show testosterone rising; two erection trials pooled show nothing. EFSA declined to clear the extract after a DNA-damage signal, and 26% of Malaysian products once tested over the mercury limit.Early clinical
- FenugreekHerbal seed extractA kitchen spice whose seed extracts are sold to men for testosterone. Seven trials pooled show a small rise in total testosterone (SMD 0.32), most of it from branded extracts with manufacturer involvement. The better-founded effect is on blood sugar in people with diabetes.Early clinical
- Fadogia agrestisHerbal stem extractA Nigerian shrub sold to men on the strength of a 2005 rat study. There is no human trial of any kind. The same rat lab found testicular changes at every dose after 28 days and membrane damage in liver and kidney. It is here so nobody has to find that out after buying it.Preclinical
Peptides
8- IpamorelinGhrelin receptor agonist / growth hormone secretagogueA selective growth hormone secretagogue that reached phase II for postoperative ileus and was discontinued after missing its endpoints. A useful case study in what a negative trial looks like.Early clinical
- CJC-1295Growth hormone-releasing hormone (GHRH) analogA GHRH analog with early human pharmacokinetic data and no efficacy program. The DAC and non-DAC versions are pharmacologically very different and are constantly conflated.Early clinical
- SermorelinGrowth hormone-releasing hormone (GHRH) analogThe shortest active GHRH fragment. Once approved, withdrawn commercially rather than for safety, and now mostly encountered as a compounded preparation.Early clinical
- GHRP-6Ghrelin receptor agonist / growth hormone secretagogueAn early growth hormone secretagogue, notable mostly for producing intense hunger and for raising cortisol and prolactin alongside GH.Early clinical
- HexarelinGhrelin receptor agonist / growth hormone secretagogueA potent GH secretagogue with pronounced tachyphylaxis and a separate cardiac literature that is more interesting than its GH effects.Preclinical
- Kisspeptin-10 (KP-10)Kisspeptin receptor (KISS1R) agonistThe upstream trigger of the reproductive axis, with genuine ongoing academic human research. One of the more scientifically respectable entries at this end of the ladder.Early clinical
- GonadorelinDecapeptide hypothalamic releasing hormoneThe native GnRH decapeptide. An established diagnostic and fertility agent whose popular use, restarting suppressed testosterone production, is the use with the least evidence behind it.Established
- GHRP-2Growth hormone secretagogue (ghrelin receptor agonist)A ghrelin receptor agonist with real human pharmacology behind it, approved in Japan as a diagnostic agent, and zero registered trials for anything people actually use it for.Early clinical
Community
Talk it through in the Testosterone & Hormones room.
The guides say what the studies found. The room is where people compare what happened to them, and every post is labeled as anecdote or cited research so the two are never confused. Reading and posting take a free account.
For Research & Educational Discussion Only. Not Medical Advice
Everything on Baseline is community discussion and educational material. It is not medical care, diagnosis, treatment, or prescribing, and no one here is acting as your clinician. Talk to a licensed healthcare professional before making any decision about your health.